BRUSSELS, June 22, 2018 –UTILE Project, funded by the European Commission under the H2020 Funding Programme, organised its 1st Business and Innovation Workshop in Sofia last 15June.
The workshop gathered 9 promising health and life science projects funded under FP7 and Horizon 2020 and 4 start-ups to offer them valorisation support for their research results. The workshop focused on IP and IP management, access to finance and licensing and commercialization of innovative products. The training was led by acknowledged experts specialized in IPR, funding opportunities and licensing.
Valorisation of research results for ended health-related EC-funded projects
UTILE project aims at carrying forward FP7 Health and Horizon2020 SC1 project results by set of online and offline tools such as trainings, workshops and brokerage events. The 1st Business and innovation Workshop, hosted by Europe Unlimited (EUN), focused on three main topics: IPR, access to finance and commercialisation and licencing. Mr. Arunas Berzinskas, IPR Ambassador from the Lithuanian Innovation Centre presented the various support services in the area of IPR in Europe. Ms. Lian van Amerongen from PNO, Nederland continued with sharing her vast experience on opportunities for public funding mainly through Horizon 2020 and the SME Instrument. The commercialization and licensing topic was presented by Ms. Anji Miller from LifeArc, UK. The three sessions provoked many discussions and the participants were urged to exchange experience and share the challenges they face. All 13 participants, representing 9 FP7 projects and 4 start-ups from health and life science, rated the workshop as relevant to their expectations and declared their willingness to participate in future initiatives organized by the UTILE project.
UTILE project–the marketplace for the health sector
UTILE is developing an online tool to valorize FP7 Health and Horizon2020 SC1 project results. The online community will be the place where Innovation Providers (such as research centres, universities and research groups) and Innovation Developers (such as big pharmaceutical and biotech companies) can meet each other and increase their innovation potential. The Marketplace provides services and tool boxes to improve the valorisation potential of health research projects and offer matchmaking opportunities with the industry and investors who are therefore able to find promising research ideas, ready to commercialize